Literature DB >> 6247121

Evaluation of the rabbit as a laboratory model for infectious bovine rhinotracheitis virus infection.

H W Lupton, H J Barnes, D E Reed.   

Abstract

Experimental infection of rabbits with infectious bovine rhinotracheitis virus (IBRV) produced diverse manifestations of disease which included abortion, conjunctivitis, dermatitis, vulvovaginitis, systemic infection, neonatal death and respiratory tract infection. Each disease syndrome was studied using virus isolation, fluorescent antibody examination and histologic examination. Conjunctivitis, dermatitis and vulvovaginitis lesions were characterized by edema, infiltration of mucosa and submucosa with inflammatory cells and ulceration of epithelium. Systemic infection resulted in severe necrosis of liver and adrenal glands with large numbers of cells containing intranuclear inculsions. Pregnant rabbits aborted within 48 hours following inoculation of IBRV. Virus infection and viral lesions were not demonstrated in aborted fetuses.

Entities:  

Mesh:

Year:  1980        PMID: 6247121

Source DB:  PubMed          Journal:  Cornell Vet        ISSN: 0010-8901


  4 in total

1.  Evaluation of crude larval protein and recombinant somatic protein 26/23 (rHcp26/23) immunization against Haemonchuscontortus in sheep.

Authors:  Omnia M Kandil; Khaled A Abdelrahman; Hatem A Shalaby; Seham H M Hendawy; Nadia M T Abu El Ezz; Somia A Nassar; James E Miller
Journal:  Vet World       Date:  2017-07-08

2.  Propagation of infectious bovine rhinotracheitis (bovine herpes-1) virus in murine primary cell cultures.

Authors:  A Ghram; H Minocha
Journal:  Vet Res Commun       Date:  1986-01       Impact factor: 2.459

3.  Experimental reactivation of bovine herpesvirus 1 (BHV-1) by means of corticosteroids in an intranasal rabbit model.

Authors:  G A Brown; H J Field
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Persistent infection with bovine herpesvirus type 1: rabbit model.

Authors:  D L Rock; D E Reed
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.